Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 10 Sept 2026 for Takeda Pharmaceutical Company Limited, €545k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Lauren Rusckowski Duprey: trading record in brief
This profile gathers the share dealings of Lauren Rusckowski Duprey in Takeda Pharmaceutical Co Ltd. We count 2 filings; the first trade dates from 13 July 2026 and the latest from 10 September 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 10 September 2026 came the latest disclosure, a transaction for €545k in Takeda Pharmaceutical Co Ltd. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Lauren Rusckowski Duprey
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
34,535 shares@ US$18.37American Depositary Shares (ADSs)SEC144:0001493152-26-042079
51,579 shares@ US$16.75100.0% of flowAmerican Depositary Shares (ADSs)SEC144:0001395064-26-000322
2 of 2 declarations
